Polish Enterprise Fund VII, fund of Enterprise Investors reached an agreement to acquire Center for Cancer Diagnostics and Therapy from Voxel S.A. (WSE:VOX) for PLN 11 million on September 21, 2012. Enterprise Investors already made an upfront payment of PLN 5 million, with the remainder payable at a later date, subject to certain conditions. Enterprise Investors will finance the development of the radiotherapy center in cooperation with a private company and a medical university.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
93.2 PLN | -1.06% | -1.27% | +18.58% |
May. 27 | Voxel S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 11 | Amadeus IT Group Buys Voxel Media in EUR113 Million Deal | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+18.58% | 248M | |
-24.16% | 7.76B | |
+68.65% | 4.33B | |
-2.98% | 2.64B | |
+2.72% | 2.63B | |
-46.17% | 2.16B | |
-22.12% | 1.46B | |
+13.62% | 1.17B | |
-43.81% | 1.14B | |
+20.41% | 999M |
- Stock Market
- Equities
- VOX Stock
- News Voxel S.A.
- Polish Enterprise Fund VII, fund of Enterprise Investors reached an agreement to acquire Center for Cancer Diagnostics and Therapy from Voxel S.A. for PLN 11 million.